SCHEMBL24425586

SCHEMBL24425586

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc4c5c(ccc6c7ccccc7n(-c7ccccc7)c65)n(-c5ccccc5)c4c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ JAK2 O60674 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ TSPO P30536 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MAPK8 P45983 1/20 0.30
▸ PTGER4 P35408 1/20 0.30
▸ KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31869 0.94 L3MBTL1 (0.46) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL24252004 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16773634 0.93 KDM4E (0.45) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL15582830 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL12196555 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL18505027 0.91 L3MBTL1 (0.46) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL17248279 0.91 L3MBTL1 (0.41) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL16773355 0.91 KDM4E (0.43) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL15582834 0.91 KDM4E (0.43) L3MBTL1KDM4EATMJAK2JAK3
SCHEMBL21128781 0.90 L3MBTL1 (0.44) L3MBTL1KDM4EATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11825744-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-11825744-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-21 — — US disclosed
US-11335860-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11335860-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device PIEZO1, OCIAD1, AQP1 L3MBTL1 641/4885KDM4E 1705/4885ATM 2809/4885
US-11825744-B2 Organic electroluminescence device and condensed cyclic compound for organic electroluminescence device PIEZO1, OCIAD1, AQP1 L3MBTL1 641/4885KDM4E 1705/4885ATM 2809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback